CSIMarket
 
Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Quest Diagnostics Inc Income Statement Quarterly

DGX


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 1,956.00 1,953.00 -
Other Revenue - - -
Total Revenue 1,926.00 1,956.00 1,953.00 1,891.00 1,839.00
Cost of Revenue 1,264.00 1,264.00 1,265.00 1,244.00 1,288.00
Gross Profit 662.00 692.00 688.00 647.00 604.00
Selling, Administration, Marketing 349.00 362.00 362.00 384.00 -1,043.00
Gain (Loss) on Disposition of Business - - - - 4.00
Depriciation & Amortization 24.00 23.00 25.00 24.00 -28.00
Research & development - - - - -
Restructuring charges - - - - -
Other exp. /-income -74.00 -6.00 -6.00 -9.00 -3.00
Special charge - - - - -
Total operating costs including COS 1,563.00 1,643.00 1,646.00 1,643.00 1,600.00
Operating income/-loss 363.00 313.00 307.00 248.00 -640.00
Other Deductions / - Income
Interest expense 42.00 44.00 45.00 44.00 47.00
Interest income - - - - -
Net interest expense/-income 130.00 44.00 45.00 -44.00 129.00
Loss (Income) from Equity Method Investments -13.00 - - -13.00 12.00
Minority Interests Income/ -Loss - - - - -
Sale of assets - - - - -
Financing Loss/ -Income - - - - -
Other loss/ -income -82.00 -1.00 -3.00 4.00 -43.00
Total costs & expenses 1,598.00 1,686.00 1,688.00 1,678.00 -3,311.00
Income /-loss before income taxes 328.00 270.00 265.00 213.00 -599.00
Income taxes expenses/-benefit 72.00 62.00 63.00 50.00 159.00
Income after income taxes 265.00 226.00 219.00 176.00 197.00
Net income/-loss of other equity 9.00 18.00 17.00 13.00 14.00
Income/-loss from cont. Ops. 265.00 226.00 219.00 176.00 197.00
Accounting change - - - - -
Discontinued operations - - 20.00 - -
Extraordinary items - - - - -
Net Income/-loss 265.00 226.00 239.00 176.00 139.00
Noncontrolling interests 12.00 11.00 13.00 12.00 12.00
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 253.00 215.00 226.00 164.00 127.00
EBIT 458.00 314.00 310.00 169.00 -470.00
EBITD 540.00 396.00 391.00 253.00 -389.00
EBITDA 540.00 396.00 391.00 253.00 -389.00


Per Share (GAAP Quarterly, in $) (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Basic EPS (excl. extra items) 1.87 1.59 1.52 1.22 1.35
   Extraordinary items 0.00 0.00 0.15 0.00 0.00
Basic Net EPS 1.87 1.59 1.67 1.22 0.93
Basic shares outstanding (Mill. of Units) 135.62 135.00 135.00 134.00 137.07
   EPS other shares - - - - -
Diluted Net EPS 1.84 1.56 1.66 1.20 0.92
Diluted average shares (Mill. of Units) 137.50 137.00 136.00 136.00 138.16
Dividend per share 0.516 0.526 0.522 0.529 0.492



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com